---
title: "ALRN.US (ALRN.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ALRN.US/news.md"
symbol: "ALRN.US"
name: "ALRN.US"
parent: "https://longbridge.com/zh-HK/quote/ALRN.US.md"
datetime: "2026-03-14T18:04:16.258Z"
locales:
  - [en](https://longbridge.com/en/quote/ALRN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALRN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALRN.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ALRN.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/ALRN.US/news.md)


# ALRN.US (ALRN.US) — 相關新聞

### [](https://longbridge.com/zh-HK/news/278597185.md)
*2026-03-10T17:28:34.000Z*
> Alector shares are trading higher after BTIG upgraded the stock from Neutral to Buy rating and announced a $6 price targ

### [03:30 ETLario Therapeutics awarded $2.4m by The Michael J. Fox Foundation and Wellcome to expand neuronal calcium channel platform across CNS disorders](https://longbridge.com/zh-HK/news/276314720.md)
*2026-02-19T08:32:16.000Z*
> Lario Therapeutics has been awarded $2.4 million in grants from The Michael J. Fox Foundation and Wellcome to expand its

### [Aileron Therapeutics Announces Rebranding to Rein Therapeutics | ALRN Stock News](https://longbridge.com/zh-HK/news/224610416.md)
*2025-01-10T16:30:00.000Z*
> Rein Therapeutics, formerly Aileron Therapeutics, has announced its rebranding to reflect its focus on developing therap

### [Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update](https://longbridge.com/zh-HK/news/216745460.md)
*2024-10-14T11:52:00.000Z*
> Aileron Therapeutics, Inc. (NASDAQ:ALRN) experienced a 15.8% increase in short interest in September, totaling 297,800 s

### [Nantahala Capital Management LLC Raises Stock Holdings in Aileron Therapeutics, Inc. (NASDAQ:ALRN)](https://longbridge.com/zh-HK/news/215699669.md)
*2024-10-01T10:11:18.000Z*
> Nantahala Capital Management LLC increased its stake in Aileron Therapeutics, Inc. (NASDAQ:ALRN) by 82.1% in Q2, now own

### [Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 13.4% in September](https://longbridge.com/zh-HK/news/215487299.md)
*2024-09-28T10:57:24.000Z*
> Aileron Therapeutics, Inc. (NASDAQ:ALRN) experienced a 13.4% decrease in short interest in September, with 257,100 share

### [Aileron Therapeutics Got Into Equity Distribution Agreement, May Offer & Sell Shares Of Our Common Stock From Time To Time Of Up To $50M](https://longbridge.com/zh-HK/news/209977531.md)
*2024-07-26T20:40:54.000Z*
> Aileron Therapeutics has entered into an equity distribution agreement, allowing them to offer and sell up to $50 millio

### [Insider Selling: Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Sells 6,291 Shares of Stock](https://longbridge.com/zh-HK/news/205874893.md)
*2024-06-07T23:33:23.000Z*
> Major shareholder of Aileron Therapeutics, Inc. sold 6,291 shares of stock at an average price of $3.30, totaling $20,76

### [Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Large Increase in Short Interest](https://longbridge.com/zh-HK/news/205069547.md)
*2024-05-29T08:11:13.000Z*
> Aileron Therapeutics, Inc. has seen a significant increase in short interest during the month of May. There was a total